Hematopoietic Stem Cells Transplantation Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Hematopoietic Stem Cells Transplantation (HSCT) Market Analysis

The hematopoietic stem cell transplantation market is expected to register a CAGR of 6.2% over the forecast period.

The outbreak of the COVID-19 pandemic has pushed the healthcare industry into action, with a race to develop both therapeutic and diagnostic devices. Exponentially increasing cases of the coronavirus globally are leading to the need for the development of novel treatments, with several clinical trials underway. Meanwhile, the overall healthcare industry was highly focused on developing vaccines and drugs, which can also be applied in the diagnosis and treatment of COVID-19, increasing the rate of clinical trials to a great extent. The market witnessed slow growth during the pandemic as the treatment of leukemia was delayed in many countries. For instance, according to the study titled, "COVID-19 infection in patients with acute leukemia; Istanbul experience" published in August 2021, the proper management of acute leukemia is necessary as it may lead to death if it is not treated promptly. This became a challenge during the pandemic. In addition, several guidelines were also published to decrease mortality in acute leukemia patients. Moreover, it also stated that the management of leukemia patients with COVID-19 infection was also very challenging during the pandemic. Hematopoietic stem cell transplantation is one of the effective treatments for leukemia. Therefore, such instances indicate that the market witnessed a slow growth rate during the pandemic.

The increasing incidence of leukemia and lymphoproliferative disorders and increasing R&D activities by biotechnology companies are the major drivers for the market. According to the data published by the Leukemia & Lymphoma Society (LLS) in 2021, around 61,090 people were estimated to be diagnosed with leukemia 2021. In addition, it also reported that around 397,501 people were living with or in remission from leukemia in the United States in 2021. Furthermore, it also stated that around every 3 minutes, one person in the United States was diagnosed with leukemia, lymphoma, or myeloma. Similarly, according to the study titled, "Rates and trends of childhood acute lymphoblastic leukemia: an epidemiology study" published in April 2021, acute lymphoblastic leukemia (ALL) is the most common cancer in childhood, with a prevalence of up to 25.0% of cancers in children who are under the age of 15 years. Hence, these factors are expected to drive the market growth.

However, the high cost associated with the transplantation procedures may likely hinder the market growth over the forecast period.

Hematopoietic Stem Cells Transplantation (HSCT) Market Trends

This section covers the major market trends shaping the Hematopoietic Stem Cell Transplantation Market according to our research experts:

Bone Marrow Transplant Segment is Expected to Witness Growth Over the Forecast Period

Hematopoietic Stem Cells Transplantation (HSCT) Industry Segmentation

As per the scope of the report, hematopoietic stem cell transplantation is a procedure that involves the intravenous infusion of autologous or allogeneic stem cells to reestablish hematopoietic function in patients whose bone marrow or immune system is damaged or defective. The hematopoietic stem cell transplantation market is segmented by Type (Autologous Transplant and Allogenic Transplant), Indication (Leukemia, Lymphoproliferative Disorders, and Non-Malignant Disorders), Application (Bone Marrow Transplant, Peripheral Blood Stem Cell Transplant, and Cord Blood Transplant), and Geography (North America, Europe, Asia-Pacific, Middle East, and Africa, and South America. The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.